• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

神经肌肉疾病患者 COVID-19 疫苗接种管理方面的未满足需求。

Unmet needs on the management of COVID-19 vaccination in patients with neuromuscular disorders.

机构信息

Department of Medical Translational Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Naples, Italy.

Cardiomyology and Medical Genetics, University of Campania "Luigi Vanvitelli", Naples, Italy.

出版信息

Acta Myol. 2021 Sep 30;40(3):113-115. doi: 10.36185/2532-1900-051. eCollection 2021 Sep.

DOI:10.36185/2532-1900-051
PMID:34632292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8489168/
Abstract

COVID-19 outbreak has quickly reached alarming morbidity and mortality with vaccines being the only weapon to fight. Although the critical situation, no international guidelines on the vaccination management of patients with neuromuscular disorders (NMDs) has still been issued. We aimed to address some unmet needs about the management of COVID-19 vaccination in patients with NMDs.

摘要

COVID-19 疫情迅速蔓延，发病率和死亡率令人震惊，疫苗是唯一的对抗手段。尽管情况危急，但目前仍未发布关于神经肌肉疾病（NMD）患者疫苗接种管理的国际指南。我们旨在解决 NMD 患者 COVID-19 疫苗接种管理方面的一些未满足需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/8489168/e9676d2f77f4/am-2021-03-113-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/8489168/13b4d767c8f7/am-2021-03-113-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/8489168/e9676d2f77f4/am-2021-03-113-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/8489168/13b4d767c8f7/am-2021-03-113-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/8489168/e9676d2f77f4/am-2021-03-113-g002.jpg

相似文献

1
Unmet needs on the management of COVID-19 vaccination in patients with neuromuscular disorders.神经肌肉疾病患者 COVID-19 疫苗接种管理方面的未满足需求。
Acta Myol. 2021 Sep 30;40(3):113-115. doi: 10.36185/2532-1900-051. eCollection 2021 Sep.
2
Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.医生-我应该接种 COVID-19 疫苗吗？神经肌肉疾病个体的感染与免疫
Muscle Nerve. 2021 Mar;63(3):294-303. doi: 10.1002/mus.27179. Epub 2021 Jan 27.
3
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.关于自身免疫性炎症性风湿病患者接种 COVID-19 疫苗的观点。
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2021-001594.
4
Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.炎症性风湿病患者接种 SARS-CoV-2 疫苗：疫苗广泛可用前的考虑因素。
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2020-001553.
5
SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.除一剂疫苗外，为新冠病毒疾病幸存者接种严重急性呼吸综合征冠状病毒2型疫苗。
EBioMedicine. 2021 Jun;68:103401. doi: 10.1016/j.ebiom.2021.103401. Epub 2021 May 26.
6
Pediatric neuromuscular disorders: Care considerations during the COVID-19 pandemic.小儿神经肌肉疾病：2019年冠状病毒病大流行期间的护理考量
J Pediatr Rehabil Med. 2020;13(3):405-414. doi: 10.3233/PRM-200768.
7
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"?SARS-CoV-2 大流行凸显的神经肌肉疾病的脆弱性和关键问题：有多少患者仍然“隐形”？
Acta Myol. 2022 Mar 31;41(1):24-29. doi: 10.36185/2532-1900-065. eCollection 2022 Mar.
8
Equitable access to COVID-19 vaccination: a distant dream?公平获得新冠疫苗接种：一个遥不可及的梦想？
Eur J Public Health. 2020 Dec 11;30(6):1039-1040. doi: 10.1093/eurpub/ckaa190.
9
Consensus on disease control objectives in the context of COVID-19 vaccines.关于新冠疫苗背景下疾病控制目标的共识。
Bull World Health Organ. 2021 May 1;99(5):322. doi: 10.2471/BLT.20.283846.
10
COVID-19 in Latin America-emergency and opportunity.拉丁美洲的新冠疫情——紧急情况与机遇
Lancet. 2021 Jul 10;398(10295):93. doi: 10.1016/S0140-6736(21)01551-8.

引用本文的文献

1
A Comprehensive Review of Neuromuscular Manifestations of COVID-19 and Management of Pre-Existing Neuromuscular Disorders in Children.新型冠状病毒肺炎（COVID-19）儿童神经肌肉表现及既往神经肌肉疾病管理的综合综述
J Clin Med. 2022 Feb 11;11(4):934. doi: 10.3390/jcm11040934.

本文引用的文献

1
Immunization in multiple sclerosis and other childhood immune-mediated disorders of the central nervous system: A review of the literature.多发性硬化症和其他儿童中枢神经系统免疫介导疾病的免疫接种：文献综述。
Eur J Paediatr Neurol. 2021 Jul;33:125-134. doi: 10.1016/j.ejpn.2021.06.002. Epub 2021 Jun 17.
2
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者接种三剂mRNA新冠疫苗
N Engl J Med. 2021 Aug 12;385(7):661-662. doi: 10.1056/NEJMc2108861. Epub 2021 Jun 23.
3
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
4
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.单剂 Ad26.COV2.S 疫苗预防新冠病毒的安全性和有效性。
N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.
5
Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders.医生-我应该接种 COVID-19 疫苗吗？神经肌肉疾病个体的感染与免疫
Muscle Nerve. 2021 Mar;63(3):294-303. doi: 10.1002/mus.27179. Epub 2021 Jan 27.
6
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
7
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
8
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中，观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性（COV002）。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
9
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase.评估新冠疫情对意大利神经肌肉疾病中心所提供服务的影响：意大利肌病协会急性期调查
Acta Myol. 2020 Jun 1;39(2):57-66. doi: 10.36185/2532-1900-008. eCollection 2020 Jun.
10
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic.新型冠状病毒大流行时期神经肌肉疾病患者的管理。
J Neurol. 2021 May;268(5):1580-1591. doi: 10.1007/s00415-020-10149-2. Epub 2020 Aug 17.